Melatonin-Based Therapeutics for Neuroprotection in Stroke

Author： Shinozuka Kazutaka   Staples Meaghan   Borlongan Cesar V.  

Publisher： MDPI

E-ISSN： 1422-0067|14|5|8924-8947

ISSN： 1422-0067

Source： International Journal of Molecular Sciences, Vol.14, Iss.5, 2013-04, pp. : 8924-8947

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Neuroprotection for Stroke: Current Status and Future Perspectives

By Minnerup Jens   Sutherland Brad A.   Buchan Alastair M.   Kleinschnitz Christoph  

International Journal of Molecular Sciences, Vol. 13, Iss. 9, 2012-09 ,pp. : 11753-11772

MDPI

Access to resources Recommend Favorite

Neuroprotection for Ischemic Stroke: Moving Past Shortcomings and Identifying Promising Directions

By Turner Ryan C.   Lucke-Wold Brandon   Lucke-Wold Noelle   Elliott Alisa S.   Logsdon Aric F.   Rosen Charles L.   Huber Jason D.  

International Journal of Molecular Sciences, Vol. 14, Iss. 1, 2013-01 ,pp. : 1890-1917

MDPI

Access to resources Recommend Favorite

Neuroglobin, a Novel Target for Endogenous Neuroprotection against Stroke and Neurodegenerative Disorders

By Yu Zhanyang   Liu Ning   Liu Jianxiang   Yang Kevin   Wang Xiaoying  

International Journal of Molecular Sciences, Vol. 13, Iss. 6, 2012-06 ,pp. : 6995-7014

MDPI

Access to resources Recommend Favorite

CELL-SELEX: Novel Perspectives of Aptamer-Based Therapeutics

By Guo Ke-Tai   Paul Angela   Schichor Christian   Ziemer Gerhard   Wendel Hans P.  

International Journal of Molecular Sciences, Vol. 9, Iss. 4, 2008-04 ,pp. : 668-678

MDPI

Access to resources Recommend Favorite

Nanoparticle-Based Delivery of RNAi Therapeutics: Progress and Challenges

By Zhou Jiehua   Shum Ka-To   Burnett John C.   Rossi John J.  

Pharmaceuticals, Vol. 6, Iss. 1, 2013-01 ,pp. : 85-107

MDPI

Access to resources Recommend Favorite